Wanbangde Pharmaceutical Holding Group: Announcement of the resolutions of the Ninth Meeting of the Ninth Board of Directors.
Wanbangde Pharmaceutical Holding Group: Guohao Lawyer (Hangzhou) Firm's Special Inspection Opinions on the Company's Actual Controller's Increased Shareholding
Wanbangde Pharmaceutical Holding Group: 0020.82 million Bond Investor Relations Management Information 20240510
Wanbangde Pharmaceutical Holding Group: Announcement on holding the 2023 online results briefing
Wanbangde Pharmaceutical Holding Group: Announcement of Board Resolutions
Wanbangde Pharmaceutical Holding Group: Announcement of Supervisory Board Resolutions
Wanbangde Pharmaceutical Holding Group: Annual special audit report on the expenditure of related parties' funds
Wanbangde Pharmaceutical Holding Group: The opinion of the board of supervisors on the company's internal control evaluation report
Wanbangde Pharmaceutical Holding Group: Announcement on the renewal of the 2024 Audit Institution
Wanbangde Pharmaceutical Holding Group: Independent Director's Debriefing Report (Zhang Yanzhou)
Wanbangde Pharmaceutical Holding Group: Nomination Committee Rules of Procedure (2024.4)
Wanbangde Pharmaceutical Holding Group: 2023 Board Work Report
Wanbangde Pharmaceutical Holding Group: Internal Control Audit Report
Wanbangde Pharmaceutical Holding Group: Announcement on providing financial support to holding subsidiaries
Wanbangde Pharmaceutical Holding Group: Remuneration management system for directors, supervisors and senior management
Wanbangde Pharmaceutical Holding Group: Independent Director's Debriefing Report (Li Yang)
Wanbangde Pharmaceutical Holding Group: The Board's Special Opinions on Evaluating the Independence of Independent Directors
Wanbangde Pharmaceutical Holding Group: 2023 Annual Audit Report
Wanbangde Pharmaceutical Holding Group: Announcement of Supervisory Board Resolutions
Wanbangde Pharmaceutical Holding Group: Audit Committee Rules of Procedure (2024.4)
No Data
No Data